Ichiro Iwanaga
About
In The Last Decade
Ichiro Iwanaga
17 papers receiving 202 citations
Peers
Comparison fields: 5 of 30
- Pulmonary and Respiratory Medicine 143
- Oncology 128
- Surgery 51
- Gastroenterology 37
- Hepatology 28
Countries citing papers authored by Ichiro Iwanaga
This map shows the geographic impact of Ichiro Iwanaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ichiro Iwanaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ichiro Iwanaga more than expected).
Fields of papers citing papers by Ichiro Iwanaga
This network shows the impact of papers produced by Ichiro Iwanaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ichiro Iwanaga. The network helps show where Ichiro Iwanaga may publish in the future.
Co-authorship network of co-authors of Ichiro Iwanaga
This figure shows the co-authorship network connecting the top 25 collaborators of Ichiro Iwanaga. A scholar is included among the top collaborators of Ichiro Iwanaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ichiro Iwanaga. Ichiro Iwanaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 4 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 55 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 79 | |
| 11 | 17 | |
| 12 | 1 | |
| 13 | 23 | |
| 14 | [A case of sigmoid colon cancer with temporary dysarthria associated with irinotecan]. | 3 |
| 15 | [A case of sigmoid colon cancer with lymphangitis carcinomatosa successfully treated with chemotherapies including molecular targeting drugs]. | 1 |
| 16 | 4 | |
| 17 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.